Whitehawk Therapeutics, Inc.
WHWK · Pharmaceutical Preparations
Latest available SEC filing: 4/A ·
Latest disclosures
-
Giacobello Scott M.: Form 4/A
Insider disclosure · Filed · Report period 15 Sep 2026
-
Form 4/A
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- WHWK · 00032Q104 - Common Stock, par value $0.0001 per share
Company details and SEC sources
CIK 0001422142 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- WHWK on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 2 Headquarters Plaza, East Building, 11 Th Floor, Morristown, NJ, 07960
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Aadi Bioscience, Inc. (to 18 Mar 2025), Aerpio Pharmaceuticals, Inc. (to 23 Aug 2021), ZETA ACQUISITION CORP II (to 13 Mar 2017)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields